Inventor · disambiguated record
Pablo A. Gonzalez Munoz
Also filed as: GONZALEZ MUNOZ PABLO ALBERTO · GONZALEZ MUÑOZ PABLO · GONZALEZ-MUNOZ PABLO A
6 granted patents·2 pending applications·8 citations·filing 2008–2021
74Inventor score
Files withUNIV PONTIFICIA CATOLICA CHILE4ALBERT EINSTEIN COLLEGE MEDICINE INC2ALBERT EINSTEIN COLLEGE MEDICINE1KALERGIS PARRA ALEXIS MIKES1
Top patents by PatentIndex Score
8 records- 0179US9999665B2Recombinant herpes simplex virus 2 (HSV-2) vaccine vectorsALBERT EINSTEIN COLLEGE MEDICINE INC·Filed 2016·Granted Jun 19, 2018·2 cites·12 claims
- 0275US10076568B2Recombinant herpes simplex virus 2 (HSV-2) vaccine vectorsALBERT EINSTEIN COLLEGE MEDICINE INC·Filed 2017·Granted Sep 18, 2018·1 cites·21 claims
- 0374US8398993B2Immunogenic formulationKALERGIS PARRA ALEXIS MIKES·Filed 2008·Granted Mar 19, 2013·5 cites·18 claims
- 0470US10751411B2Recombinant herpes simplex virus 2 (HSV-2) vaccine vectorsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2019·Granted Aug 25, 2020·0 cites·9 claims
- 0556US12247066B2Monoclonal antibody 14F5F6 or fragment thereof, that specifically recognizes herpes simplex virus 1 and 2UNIV PONTIFICIA CATOLICA CHILE·Filed 2018·Granted Mar 11, 2025·0 cites·14 claims
- 0656US12098185B2Monoclonal antibody 11B2C7 or fragment thereof, that specifically recognizes herpes simplex virus 1 and 2UNIV PONTIFICIA CATOLICA CHILE·Filed 2018·Granted Sep 24, 2024·0 cites·12 claims
- 0756US2024042012A1IMMUNOGENIC FORMULATION CONTAINING ONE OR MORE MODIFIED BCG STRAINS EXPRESSING A SARS-CoV-2 PROTEIN, USEFUL FOR PREVENTING, TREATING, OR ATTENUATING THE DEVELOPMENT OF COVID-19UNIV PONTIFICIA CATOLICA CHILE·Filed 2021·Application pending·0 cites
- 0855US2023390378A1Immunogenic formulation containing a modified bcg strain expressing an andesvirus protein (andv) useful for preventing and treating hanta-andv virus infectionsUNIV PONTIFICIA CATOLICA CHILE·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pablo A. Gonzalez Munoz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →